Orchid Pharma

{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,081.80",
    "chg": 92.1,
    "chgp": "9.31%",
    "dir": 1,
    "prev_price": "989.70",
    "mcapval": "6,138.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE191A01027",
    "curr_date": "Sep 21, 03:58 PM",
    "curr_time": "17:26 PM",
    "last_traded_at": "Sep 21, 03:58 PM IST",
    "bse_nse_vol": "5.97 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 21, 2026",
    "traded_date_str": "2026 09 21",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/orchid-pharma-653435-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Orchid Pharma Ltd Surges 7.28% to Day's High of Rs 1070.3 — Outperforms Sector by 6.8 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-hits-intraday-high-with-728-surge-on-21-sep-2026-4199981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OrchidPharmaLtd_priceRelatedfactors_4199981.png",
        "date": "2026-09-21 12:02:16",
        "description": "The Sensex advanced 0.77% on 21 Sep 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.28% gain, reaching an intraday high of Rs 1070.3. This 6.8 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-hold-4198632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OrchidPharmaLtd_mojoScore_4198632.png",
        "date": "2026-09-20 10:10:42",
        "description": "Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-hold-by-marketsmojo-4187789",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OrchidPharmaLtd_mojoScore_4187789.png",
        "date": "2026-09-09 10:11:39",
        "description": "Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-hold-by-marketsmojo-4174083",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OrchidPharmaLtd_mojoScore_4174083.png",
        "date": "2026-08-29 10:10:25",
        "description": "Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4170854",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OrchidPharmaLtd_technicaldot_4170854.png",
        "date": "2026-08-27 08:02:40",
        "description": "Orchid Pharma Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late August 2026. Despite a sharp day decline of 6.45%, the stock’s longer-term technical indicators suggest a cautiously optimistic outlook, supported by mixed signals from MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Orchid Pharma Ltd Falls 4.74%: 4 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-falls-474-4-key-factors-driving-the-weekly-decline-4165465",
        "imagepath": "",
        "date": "2026-08-22 16:04:54",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> Intraday low amid price pressure, stock hits Rs.942</p>\n                    <p><strong>18 Aug:</strong> Quality grade upgraded to average, Mojo Score rises to 58.0</p>\n                    <p><strong>18 Aug:</strong> Investment rating upgraded from Sell to Hold by MarketsMOJO</p>\n                    <p><strong>19 Aug:</strong> Technical momentum shifts to mildly bullish amid mixed signals</p>\n                    <p><strong>21 Aug:</strong> Week closes at Rs.997.45, down 4.74%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,047.10</div><..."
      },
      {
        "title": "Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-4160377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OrchidPharmaLtd_technicaldot_4160377.png",
        "date": "2026-08-19 08:03:03",
        "description": "Orchid Pharma Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance, reflecting a nuanced change in market sentiment. Despite a recent decline of 2.95% in daily price, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes that investors should carefully analyse."
      },
      {
        "title": "Orchid Pharma Ltd Upgraded to Hold as Quality and Valuation Metrics Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-upgraded-to-hold-as-quality-and-valuation-metrics-improve-4159023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OrchidPharmaLtd_mojoScore_4159023.png",
        "date": "2026-08-18 08:16:59",
        "description": "Orchid Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its overall outlook. This change is driven by improvements in quality metrics, tempered valuation concerns, mixed financial trends, and cautious technical signals. Despite recent challenges, the company’s long-term market-beating returns and institutional backing have contributed to this reassessment."
      },
      {
        "title": "Orchid Pharma Ltd Quality Grade Upgrade Signals Improving Business Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-quality-grade-upgrade-signals-improving-business-fundamentals-4158425",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/OrchidPharmaLtd_qualitydot_4158425.png",
        "date": "2026-08-18 08:00:15",
        "description": "Orchid Pharma Ltd has seen its quality grade improve from below average to average, reflecting a nuanced shift in its business fundamentals. While key metrics such as return on equity (ROE) and return on capital employed (ROCE) remain modest, the company’s growth trajectory and debt profile reveal both encouraging and cautionary signals for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 378,
    "sid": "653435",
    "stock_news_url": "https://www.marketsmojo.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "details": "Orchid Pharma Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from December 23, 2019 to December 30, 2019 ( both days inclusive) for the purpose of Annual General Meeting to be held on December 30, 2019.",
      "source": "NSE",
      "caption": "Orchid Pharma Limited - AGM/Book Closure",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Orchid Pharma Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": " <table><tr><td>Orchid Pharma Limited has informed the Exchange regarding Board meeting held on August 12, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "12-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Orchid Pharma Ltd Surges 7.28% to Day's High of Rs 1070.3 — Outperforms Sector by 6.8 Percentage Points

2026-09-21 12:02:16

The Sensex advanced 0.77% on 21 Sep 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.28% gain, reaching an intraday high of Rs 1070.3. This 6.8 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Orchid Pharma Ltd is Rated Hold

2026-09-20 10:10:42

Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 20 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Orchid Pharma Ltd is Rated Hold by MarketsMOJO

2026-09-09 10:11:39

Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Orchid Pharma Ltd is Rated Hold by MarketsMOJO

2026-08-29 10:10:25

Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 29 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-27 08:02:40

Orchid Pharma Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late August 2026. Despite a sharp day decline of 6.45%, the stock’s longer-term technical indicators suggest a cautiously optimistic outlook, supported by mixed signals from MACD, RSI, moving averages, and other momentum oscillators.

Read full news article

Orchid Pharma Ltd Falls 4.74%: 4 Key Factors Driving the Weekly Decline

2026-08-22 16:04:54

Key Events This Week

17 Aug: Intraday low amid price pressure, stock hits Rs.942

18 Aug: Quality grade upgraded to average, Mojo Score rises to 58.0

18 Aug: Investment rating upgraded from Sell to Hold by MarketsMOJO

19 Aug: Technical momentum shifts to mildly bullish amid mixed signals

21 Aug: Week closes at Rs.997.45, down 4.74%

Week Open

Rs.1,047.10

<...

Read full news article

Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-19 08:03:03

Orchid Pharma Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance, reflecting a nuanced change in market sentiment. Despite a recent decline of 2.95% in daily price, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes that investors should carefully analyse.

Read full news article

Orchid Pharma Ltd Upgraded to Hold as Quality and Valuation Metrics Improve

2026-08-18 08:16:59

Orchid Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its overall outlook. This change is driven by improvements in quality metrics, tempered valuation concerns, mixed financial trends, and cautious technical signals. Despite recent challenges, the company’s long-term market-beating returns and institutional backing have contributed to this reassessment.

Read full news article

Orchid Pharma Ltd Quality Grade Upgrade Signals Improving Business Fundamentals

2026-08-18 08:00:15

Orchid Pharma Ltd has seen its quality grade improve from below average to average, reflecting a nuanced shift in its business fundamentals. While key metrics such as return on equity (ROE) and return on capital employed (ROCE) remain modest, the company’s growth trajectory and debt profile reveal both encouraging and cautionary signals for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

View All News